Development of a new family of compounds with potent anti-diabetic properties Blog Post

Researchers in the Molecular Medicine, and Chemistry and Molecular Pharmacology Programmes at the (IRB Barcelona), together with scientists with the of the Barcelona Science Park (Parc Científic de Barcelona, PCB) and , have identified a new set of compounds that show potent anti-diabetic properties that might provide a treatment for diabetes. The biotech company Genmedica Therapeutics will carry out the subsequent stages of the study on these new compounds.

The Combinatorial Chemistry Unit and UTOX join the Technological Innovation Network Blog Post

The Combinatorial Chemistry Unit () and the Experimental Toxicology and Ecotoxicology Unit () have been accepted as members of the Network of Support Centres of Technological Innovation (). This network seeks to promote the transfer of knowledge and technology from universities and public research centres to the private sector through providing R+D services. The network is characterized by the quality and excellence of research performed by its members, who conduct advanced research and activities of high added value.